11 News & Press Releases found
Siemens AG News
-
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial
Merck and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction chemotherapy in patients with unresectable, locally advanced or ...
-
The Lancet Public Health: First scientific review of menstrual cups suggests they are safe and may be as effective as other sanitary products
Review indicates that menstrual cups are a safe option for menstruation management Around 70% of women wanted to continue using menstrual cups once they were familiar with how use them, but practice, peer support and training are key to ...
-
The Lancet: Nerve transfer surgery restores hand function and elbow extension in 13 young adults with complete paralysis
Nerve transfer surgery has enabled 13 young adults with complete paralysis to regain movement and function in their elbows and hands, according to the largest case series of this technique in people with tetraplegia (paralysis of both the upper and ...
-
The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of ...
-
Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event
Merck, a leading science and technology company, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland. The panel entitled,“Leaving no one behind: from philanthropy to sustainable health ...
-
FDA Approves BAVENCIO (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma
BAVENCIO is the first anti-PD-L1 in combination with axitinib approved by FDA for first-line treatment of patients with advanced renal cell carcinoma (RCC) Phase III study showed combination significantly lowered risk of disease progression or ...
-
Merck Signs definitive agreement to acquire versum, materials for $53 per share
Business combination creates a leading electronic materials player able to capitalize on attractive long-term secular growth drivers Versum is a “Best in Class” asset with industry-leading financial metrics Expected to be immediately ...
-
Merck Files Preliminary Proxy Statement Urging Versum Shareholders to Vote Against Entegris Acquisition
Merck is convinced that the proposed Entegris acquisition is not the best option available for Versum shareholders Merck’s all-cash $48 per share proposal clearly superior to Entegris acquisition Merck, a leading science and technology ...
-
DOMO Chemicals talks about the future of polyamide at the Wood Mackenzie European Nylon Conference
Ron Bult, Director of Global Sales of DOMO Engineering Plas-tics will highlight solutions based on ECONAMID, a family of PA6 & PA66 compounds based on sustainable post-industrial feedstock derived either from film manufactur-ing or from fiber ...
-
Study reveals elevated risk of cardiovascular disease in young women who had gestational diabetes during pregnancy
New research published in Diabetologia (the journal of the European Association for Study of Diabetes [EASD]) shows that, in women who develop gestational diabetes (GDM) during pregnancy, the risk of cardiovascular disease (CVD) in the years ...
-
The Lancet Global Health: Globally, more than 1.4 billion adults are at risk of disease from not doing enough physical activity
No improvement in global levels of physical activity since 2001. Worldwide, around 1 in 3 women and 1 in 4 men do not do enough physical activity to stay healthy. Levels of insufficient physical activity are more than twice as high in ...